CVKD vs. DAL
CVKD (Cadrenal Therapeutics Inc. Common Stock) and DAL (Delta Air Lines, Inc.) are both stocks. CVKD operates in Biotechnology (Healthcare), while DAL operates in Airlines (Industrials). Over the past 3 years, CVKD returned -49.02%/yr vs 27.48%/yr for DAL. At a 0.16 correlation, their price movements are largely independent.
Performance
CVKD vs. DAL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CVKD achieves a -53.10% return, which is significantly lower than DAL's 24.47% return.
CVKD
- 1D
- -9.14%
- 1M
- -38.73%
- YTD
- -53.10%
- 6M
- -57.80%
- 1Y
- -74.25%
- 3Y*
- -49.02%
- 5Y*
- —
- 10Y*
- —
DAL
- 1D
- 2.07%
- 1M
- 12.84%
- YTD
- 24.47%
- 6M
- 19.87%
- 1Y
- 84.21%
- 3Y*
- 27.48%
- 5Y*
- 14.42%
- 10Y*
- 10.68%
CVKD vs. DAL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CVKD Cadrenal Therapeutics Inc. Common Stock | -53.10% | -53.21% | 30.56% | -87.04% |
DAL Delta Air Lines, Inc. | 24.47% | 16.09% | 52.00% | 5.42% |
Correlation
The correlation between CVKD and DAL is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jan 20, 2023 | 0.16 |
Fundamentals
CVKD:
$6.34M
DAL:
$56.02B
CVKD:
-$5.10
DAL:
$6.85
CVKD:
2.31
DAL:
2.75
CVKD:
$0.00
DAL:
$65.18B
CVKD:
-$5.92K
DAL:
$17.07B
CVKD:
-$13.32M
DAL:
$9.66B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CVKD vs. DAL — Risk / Return Rank
CVKD
DAL
CVKD vs. DAL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cadrenal Therapeutics Inc. Common Stock (CVKD) and Delta Air Lines, Inc. (DAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVKD | DAL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.79 | ||
| Sortino ratioReturn per unit of downside risk | -4.18 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.33 | -0.47 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 3.70 | -4.64 |
| Martin ratioReturn relative to average drawdown | -1.75 | 11.81 | -13.56 |
Loading charts...
Drawdowns
CVKD vs. DAL - Drawdown Comparison
The maximum CVKD drawdown since its inception was -96.45%, which is greater than DAL's maximum drawdown of -81.93%. Use the drawdown chart below to compare losses from any high point for CVKD and DAL.
Loading charts...
Drawdown Indicators
| CVKD | DAL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.45% | -81.93% | -14.52% |
Max Drawdown (1Y)Largest decline over 1 year | -78.59% | -22.90% | -55.69% |
Max Drawdown (3Y)Largest decline over 3 years | -90.99% | -47.92% | -43.07% |
Max Drawdown (5Y)Largest decline over 5 years | — | -47.92% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -69.18% | — |
Current DrawdownCurrent decline from peak | -96.29% | 0.00% | -96.29% |
Average DrawdownAverage peak-to-trough decline | -84.77% | -29.09% | -55.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.39% | 7.16% | +35.23% |
Volatility
CVKD vs. DAL - Volatility Comparison
Cadrenal Therapeutics Inc. Common Stock (CVKD) has a higher volatility of 26.09% compared to Delta Air Lines, Inc. (DAL) at 12.24%. This indicates that CVKD's price experiences larger fluctuations and is considered to be riskier than DAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CVKD | DAL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.09% | 12.24% | +13.85% |
Volatility (6M)Calculated over the trailing 6-month period | 68.56% | 30.06% | +38.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.24% | 41.43% | +58.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.28% | 41.00% | +61.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 102.28% | 42.25% | +60.03% |
Dividends
CVKD vs. DAL - Dividend Comparison
CVKD has not paid dividends to shareholders, while DAL's dividend yield for the trailing twelve months is around 0.87%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVKD Cadrenal Therapeutics Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DAL Delta Air Lines, Inc. | 0.87% | 0.97% | 0.83% | 0.50% | 0.00% | 0.00% | 1.00% | 2.57% | 2.63% | 1.81% | 1.37% | 0.89% |
Financials
CVKD vs. DAL - Financials Comparison
This section allows you to compare key financial metrics between Cadrenal Therapeutics Inc. Common Stock and Delta Air Lines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CVKD and DAL have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVKD has higher volatility (26.09%) compared to DAL (12.24%). In terms of maximum drawdown, CVKD dropped -96.45% vs DAL's -81.93%.
DAL currently has the higher Sharpe Ratio (2.05 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CVKD and DAL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer